Skip to content

Proteomics and metabonomics of renal diseases in children

Proteomics and metabonomics of renal diseases in children

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029513
Enrollment
Unknown
Registered
2020-02-03
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Henoch-Schnlein purpura?Henoch-Schnlein purpura nephritis?IgA nephropathy?Nephrotic syndrome

Interventions

Henoch-Schnlein purpura group, Henoch-Schnlein purpura nephritis group, IgA nephropathy group, Nephrotic syndrome group and healthy control group:N/A

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 18 Years

Inclusion criteria

Inclusion criteria: Observation group: 1. Children with HSP: a. With a history of typical rash, meet the HSP diagnostic criteria established by the immunology group of pediatric branch of Chinese Medical Association in 2013; b. Aged <= 18 years. 2. Children with HSPN: a. Have a typical history of Henoch-Sch?nlein purpura; b. Meet the HSPN diagnostic criteria established by the nephrology group of pediatric branch of Chinese Medical Association in 2016; c. Aged <= 18 years. 3. Children with IgA nephropathy: a. With IgA nephropathy confirmed by renal pathology; b. Aged <= 18 years. 4. Children with nephrotic syndrome: a. Meet the diagnostic criteria for children with primary nephrotic syndrome; b. Aged <= 18 years. Healthy control group: 1. Aged <= 18 years old; 2. No severe physical illness.

Exclusion criteria

Exclusion criteria: 1. Those who have been treated with hormones or immunosuppressants; 2. Those with history of drug abuse.

Design outcomes

Primary

MeasureTime frame
The level of proteins;

Countries

China

Contacts

Public ContactZhang Jianjiang

The First Affiliated Hospital of Zhengzhou University

zhangjianjiang10@163.com+86 15936269856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026